Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.48 +0.03 (+1.22%)
At close: Nov 11, 2026 · 4:00 PM EST

Rocket Pharmaceuticals (RCKT) Asset Writedowns and Impairment (2017 - 2023)

Updated

Rocket Pharmaceuticals' Asset Writedowns and Impairment was $262,000 in FY2025.

Analysis

Rocket Pharmaceuticals (RCKT) Asset Writedowns and Impairment (2017 - 2023) Analysis & Trends

  • Per Business Quant data, Asset Writedowns and Impairment in earlier years was $574,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Rocket Pharmaceuticals 268.37 Mn -15.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 574,000.00
Dec 31, 2022 59,000.00
Jun 30, 2022 137,000.00
Mar 31, 2022 40,000.00
Dec 31, 2021 261,000.00
Dec 31, 2020 357,000.00
Jun 30, 2020 -1,000.00
Mar 31, 2020 63,000.00
Dec 31, 2017 14,000.00
API Access

Rocket Pharmaceuticals Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=RCKT&period=max&api_key=YOUR_API_KEY